Status:
COMPLETED
Effects of Noninvasive Ventilation Compared to Salbutamol
Lead Sponsor:
University of Nove de Julho
Conditions:
Asthma
Eligibility:
All Genders
12-29 years
Phase:
NA
Brief Summary
Asthma is a chronic inflammatory disease characterized by recurrent and reversible episodes of airway obstruction. Drug treatment usually includes inhaled corticosteroids and bronchial dilators, which...
Detailed Description
Asthma is a chronic inflammatory disease characterized by recurrent episodes of reversible airway obstruction. The drug treatment typically includes inhaled steroids and bronco dilators. These acute e...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age 12 to 29 years
- Both sexes
- Diagnosis of asthma according to GINA
- Without deterioration in the last 30 days
- No history of respiratory infection in the last 2 months
- Comply with consent form
- EXCLUSION CRITERIA:
- Use bronchodilator under 12 hours
- No understanding of the tests
- Heart condition
- Intolerance the proposed activities
- Don't have bronchodilator prescribed by doctor
Exclusion
Key Trial Info
Start Date :
June 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03430505
Start Date
June 10 2017
End Date
December 20 2018
Last Update
July 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nove de Julho University
São Paulo, Brazil, 01.504-001